Illumina, Inc. (ETR:ILU)
Germany · Delayed Price · Currency is EUR 112.24
-0.62 (-0.55%)
Dec 1, 2025, 9:04 AM CET
Illumina Employees
As of December 29, 2024, Illumina had 9,030 total employees, including 8,970 full-time and 60 part-time employees. The number of employees decreased by 1,610 or -15.13% compared to the previous year.
Employees
9,030
Change (1Y)
-1,610
Growth (1Y)
-15.13%
Revenue / Employee
€407,455
Profits / Employee
€66,801
Market Cap
17.32B
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 29, 2024 | 9,030 | -1,610 | -15.13% |
| Dec 31, 2023 | 10,640 | -920 | -7.96% |
| Jan 1, 2023 | 11,560 | 1,710 | 17.36% |
| Jan 2, 2022 | 9,850 | 2,000 | 25.48% |
| Jan 3, 2021 | 7,850 | 150 | 1.95% |
| Dec 29, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jan 1, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jan 3, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Fresenius SE & Co. KGaA | 176,486 |
| Fresenius Medical Care AG | 111,513 |
| Bayer Aktiengesellschaft | 91,864 |
| Siemens Healthineers AG | 73,840 |
| Merck KGaA | 59,020 |
| Fielmann Group AG | 24,363 |
| Sartorius Aktiengesellschaft | 13,528 |
| Carl Zeiss Meditec AG | 5,730 |
Illumina News
- 11 days ago - Illumina, Inc. (ILMN) Presents at 7th Annual Wolfe Research Healthcare Conference Transcript - Seeking Alpha
- 18 days ago - Illumina whole-genome sequencing provides greater insight into genetic signals behind common diseases--according to Nature study - PRNewsWire
- 19 days ago - Illumina To Webcast Upcoming Investor Conference - PRNewsWire
- 19 days ago - Notable Tuesday Option Activity: ILMN, VKTX, CVNA - Nasdaq
- 19 days ago - ALKS or ILMN: Which Is the Better Value Stock Right Now? - Nasdaq
- 20 days ago - Final Trades: Morgan Stanley, Cisco Systems, Illumina and FTAI Aviation - CNBC
- 20 days ago - Illumina® Protein Prep delivers groundbreaking precision in NGS proteomics for more than 40 customers, ranging from academic institutions to large national biobanks - PRNewsWire
- 23 days ago - Illumina: An Excellent Profit Margin And The Sequencing Genome Market Will Unlock Value - Seeking Alpha